Evaluation of anti-nucleocapsid level variation to assess SARS-CoV-2 seroprevalence in a vaccinated population.
Renée BazinSamuel RochetteJosée PerreaultMarie-Josée FournierYves GrégoireAmélie BoivinAntoine LewinMarc GermainChristian RenaudPublished in: Infectious diseases (London, England) (2023)
The new analytical approach described herein captured a significantly greater proportion of vaccinated individuals with a known history of SARS-CoV-2 infection than the conventional approach used in most serosurveys.